查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1953981

日本体外诊断市场报告：按检测类型、产品类型、便利性、应用、最终用户和地区划分（2026-2034年）

Japan In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本体外诊断市场规模达51亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到63亿美元，2026年至2034年的复合年增长率为2.30%。推动市场成长的关键因素包括人口老化、技术快速进步、医疗意识增强、政府主导的措施不断扩大、个人化医疗的发展以及对研发活动的日益重视。

体外诊断（IVD）是指对取自人体的生物检体进行的各种医学检测。这些检测透过分析体外血液、尿液和组织样本来检测疾病、感染疾病和其他病症。体外诊断广泛应用于实验室、医院和专科诊所，对医疗决策、病患监测和个人化治疗至关重要。其在医疗保健领域的广泛应用有助于早期诊断和精准医疗，使医护人员能够做出明智及时的决策。作为现代医疗保健系统的重要组成部分，体外诊断促进了预防医学和治疗医学的发展，改善了患者的整体健康。它们还有助于提高医疗效率、促进早期发现并降低医疗成本。此外，体外诊断也用于监测慢性疾病并辅助治疗决策。

日本体外诊断市场趋势：

随着老龄化社会的加剧，人们对更全面、更常规的医疗检测的需求日益增长，这是推动市场成长的关键因素之一。同时，糖尿病、心血管疾病和癌症等与老龄化相关的疾病盛行率也在上升。反过来，这又透过对体外诊断（IVD）检测的需求成长，推动了市场成长，这些疾病的诊断和治疗需要IVD检测。此外，分子诊断、照护现场检测（POC​​）和自动化技术等先进技术的进步，正在提高IVD检测的准确性、速度和可及性。政府加大力度推动医疗创新，并推出用户友善、个人化的IVD解决方案，也促进了这一趋势。此外，随着消费者越来越积极主动地管理自身健康，他们越来越重视预防保健，成长要素了对健康相关诊断检测和个人化医疗解决方案的需求。此外，向个人化医疗的快速转型和分子诊断技术的进步，正在塑造日本IVD市场的未来。此外，对研发的日益重视以及诊断公司与研究机构之间合作的加强，为市场带来了盈利的成长机会。同时，巨量资料和人工智慧在诊断领域的整合、分析能力的提升以及个人化医疗服务的推行，也为市场成长创造了盈利条件。

日本体外诊断市场细分：

按测试类型分析：

本报告解答的关键问题：

  • 日本体外诊断市场目前发展状况如何？您预计未来几年它将如何发展？
  • 新冠疫情对日本体外诊断市场产生了哪些影响？
  • 日本体外诊断市场依检测类型分類的组成是怎样的？
  • 日本体外诊断市场依产品分類的组成是怎样的？
  • 日本体外诊断市场按利用率分類的市场组成为何？
  • 日本体外诊断市场按应用领域是如何分類的？
  • 日本体外诊断市场依最终用户分類的组成是怎样的？
  • 日本体外诊断市场价值链的各个阶段有哪些？
  • 日本体外诊断市场的主要驱动因素和挑战是什么？
  • 日本体外诊断市场的结构是怎么样的？主要参与者有哪些？
  • 日本体外诊断市场的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本体外诊断市场：简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章：日本体外诊断市场：现状

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本体外诊断市场－依检测类型细分

  • 临床化学
  • 分子诊断
  • 免疫诊断
  • 血液学
  • 其他的

第七章：日本体外诊断市场：依产品细分

  • 试剂和试剂盒
  • 装置

第八章：日本体外诊断市场－按应用领域细分

  • 免洗体外诊断设备
  • 可重复使用的体外诊断医疗设备

第九章：日本体外诊断市场：依应用领域细分

  • 感染疾病
  • 糖尿病
  • 癌症和肿瘤学
  • 心臟病学
  • 自体免疫疾病
  • 肾臟病学
  • 其他的

第十章：日本体外诊断市场－依最终用户细分

  • 医院检查室
  • 临床检查室
  • 就地检验中心
  • 学术机构
  • 病人
  • 其他的

第十一章：日本体外诊断市场：依地区划分

  • 关东地区
  • 近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十二章：日本体外诊断市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十三章主要企业概况

第十四章：日本体外诊断市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十五章附录

简介目录
Product Code: SR112026A11064

The Japan in vitro diagnostics market size reached USD 5.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.3 Billion by 2034, exhibiting a growth rate (CAGR) of 2.30% during 2026-2034. The rising geriatric population, rapid technological advancements, growing healthcare awareness, increasing government initiatives, development of personalized medication, enhanced focus on research and development (R&D) activities represent some of the key factors driving the market.

In vitro diagnostics (IVD) is a collection of medical tests performed using biological samples from the human body. These tests detect diseases, infections, and other medical conditions by analyzing blood, urine, or tissue samples outside the living organism. They are utilized in laboratories, hospitals, and specialized clinics and are vital in medical decision-making, patient monitoring, and personalized treatment. The increasing adoption of IVD in healthcare supports early diagnosis and precise treatment, allowing healthcare providers to make informed and timely decisions. As an essential component of modern healthcare systems, IVD contributes to the advancement of preventive and therapeutic care, enhancing overall patient well-being. It also improves healthcare efficiency, promoting early detection and reducing healthcare costs. It is also employed in monitoring chronic illnesses and assisting in therapeutic decision-making.

Japan In Vitro Diagnostics Market Trends:

The rising geriatric population necessitating more comprehensive and routine medical testing is one of the major factors contributing to the market growth. In line with this, the increasing prevalence of age-related diseases, such as diabetes, cardiovascular conditions, and cancer, prompting increased IVD tests to diagnose and manage these ailments, is propelling the market growth. Additionally, rapid technological advancements in IVD that are introducing innovative solutions with higher accuracy and efficiency, such as innovations in molecular diagnostics, point-of-care (POC) testing, and automation technologies, enhancing the precision, speed, and accessibility of IVD tests, are also creating a positive outlook for the market growth. In addition to this, the increasing government initiatives promoting healthcare innovation and the introduction of user-friendly, personalized IVD solutions are also positively impacting the market growth. Moreover, the growing awareness and emphasis on preventive healthcare as consumers are increasingly proactive in managing their health, leading to higher demand for wellness-related diagnostic tests and personalized medicine solutions, is acting as a growth-inducing factor. Furthermore, the sudden shift towards personalized medicine and the development of molecular diagnostics are shaping the future of the IVD market in Japan. Besides this, the increasing focus on research and development (R&D) and partnerships between diagnostics companies and research institutions are providing remunerative growth opportunities for the market. In addition to this, the integration of big data and artificial intelligence (AI) in diagnostics, enhancing analytical capabilities, and personalizing care is providing remunerative opportunities for the market growth.

Japan In Vitro Diagnostics Market Segmentation:

Test Type Insights:

  • Clinical Chemistry
  • Molecular Diagnostics
  • Immunodiagnostics
  • Hematology
  • Others

Product Insights:

  • Reagents and Kits
  • Instruments

Usability Insights:

  • Disposable IVD Devices
  • Reusable IVD Devices

Application Insights:

  • Infectious Disease
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Disease
  • Nephrology
  • Others

End User Insights:

  • Hospitals Laboratories
  • Clinical Laboratories
  • Point-Of-Care Testing Centers
  • Academic Institutes
  • Patients
  • Others

Regional Insights:

  • Kanto Region
  • Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include the Kanto Region, Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region and Shikoku Region.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan in vitro diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan in vitro diagnostics market?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of test type?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of product?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of usability?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of application?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Japan in vitro diagnostics market?
  • What are the key driving factors and challenges in the Japan in vitro diagnostics market?
  • What is the structure of the Japan in vitro diagnostics market and who are the key players?
  • What is the degree of competition in the Japan in vitro diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan In Vitro Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan In Vitro Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan In Vitro Diagnostics Market - Breakup by Test Type

  • 6.1 Clinical Chemistry
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Molecular Diagnostics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Immunodiagnostics
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Hematology
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2020-2025)
    • 6.5.2 Market Forecast (2026-2034)

7 Japan In Vitro Diagnostics Market - Breakup by Product

  • 7.1 Reagents and Kits
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Instruments
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)

8 Japan In Vitro Diagnostics Market - Breakup by Usability

  • 8.1 Disposable IVD Devices
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Reusable IVD Devices
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)

9 Japan In Vitro Diagnostics Market - Breakup by Application

  • 9.1 Infectious Disease
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Diabetes
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Cancer/Oncology
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Cardiology
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Forecast (2026-2034)
  • 9.5 Autoimmune Disease
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Forecast (2026-2034)
  • 9.6 Nephrology
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Forecast (2026-2034)
  • 9.7 Others
    • 9.7.1 Historical and Current Market Trends (2020-2025)
    • 9.7.2 Market Forecast (2026-2034)

10 Japan In Vitro Diagnostics Market - Breakup by End User

  • 10.1 Hospitals Laboratories
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Forecast (2026-2034)
  • 10.2 Clinical Laboratories
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)
  • 10.3 Point-of-care Testing Centers
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Forecast (2026-2034)
  • 10.4 Academic Institutes
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Forecast (2026-2034)
  • 10.5 Patients
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Forecast (2026-2034)
  • 10.6 Others
    • 10.6.1 Historical and Current Market Trends (2020-2025)
    • 10.6.2 Market Forecast (2026-2034)

11 Japan In Vitro Diagnostics Market - Breakup by Region

  • 11.1 Kanto Region
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Breakup by Test Type
    • 11.1.4 Market Breakup by Product
    • 11.1.5 Market Breakup by Usability
    • 11.1.6 Market Breakup by Application
    • 11.1.7 Market Breakup by End User
    • 11.1.8 Key Players
    • 11.1.9 Market Forecast (2026-2034)
  • 11.2 Kinki Region
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Breakup by Test Type
    • 11.2.4 Market Breakup by Product
    • 11.2.5 Market Breakup by Usability
    • 11.2.6 Market Breakup by Application
    • 11.2.7 Market Breakup by End User
    • 11.2.8 Key Players
    • 11.2.9 Market Forecast (2026-2034)
  • 11.3 Central/Chubu Region
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2020-2025)
    • 11.3.3 Market Breakup by Test Type
    • 11.3.4 Market Breakup by Product
    • 11.3.5 Market Breakup by Usability
    • 11.3.6 Market Breakup by Application
    • 11.3.7 Market Breakup by End User
    • 11.3.8 Key Players
    • 11.3.9 Market Forecast (2026-2034)
  • 11.4 Kyushu-Okinawa Region
    • 11.4.1 Overview
    • 11.4.2 Historical and Current Market Trends (2020-2025)
    • 11.4.3 Market Breakup by Test Type
    • 11.4.4 Market Breakup by Product
    • 11.4.5 Market Breakup by Usability
    • 11.4.6 Market Breakup by Application
    • 11.4.7 Market Breakup by End User
    • 11.4.8 Key Players
    • 11.4.9 Market Forecast (2026-2034)
  • 11.5 Tohoku Region
    • 11.5.1 Overview
    • 11.5.2 Historical and Current Market Trends (2020-2025)
    • 11.5.3 Market Breakup by Test Type
    • 11.5.4 Market Breakup by Product
    • 11.5.5 Market Breakup by Usability
    • 11.5.6 Market Breakup by Application
    • 11.5.7 Market Breakup by End User
    • 11.5.8 Key Players
    • 11.5.9 Market Forecast (2026-2034)
  • 11.6 Chugoku Region
    • 11.6.1 Overview
    • 11.6.2 Historical and Current Market Trends (2020-2025)
    • 11.6.3 Market Breakup by Test Type
    • 11.6.4 Market Breakup by Product
    • 11.6.5 Market Breakup by Usability
    • 11.6.6 Market Breakup by Application
    • 11.6.7 Market Breakup by End User
    • 11.6.8 Key Players
    • 11.6.9 Market Forecast (2026-2034)
  • 11.7 Hokkaido Region
    • 11.7.1 Overview
    • 11.7.2 Historical and Current Market Trends (2020-2025)
    • 11.7.3 Market Breakup by Test Type
    • 11.7.4 Market Breakup by Product
    • 11.7.5 Market Breakup by Usability
    • 11.7.6 Market Breakup by Application
    • 11.7.7 Market Breakup by End User
    • 11.7.8 Key Players
    • 11.7.9 Market Forecast (2026-2034)
  • 11.8 Shikoku Region
    • 11.8.1 Overview
    • 11.8.2 Historical and Current Market Trends (2020-2025)
    • 11.8.3 Market Breakup by Test Type
    • 11.8.4 Market Breakup by Product
    • 11.8.5 Market Breakup by Usability
    • 11.8.6 Market Breakup by Application
    • 11.8.7 Market Breakup by End User
    • 11.8.8 Key Players
    • 11.8.9 Market Forecast (2026-2034)

12 Japan In Vitro Diagnostics Market - Competitive Landscape

  • 12.1 Overview
  • 12.2 Market Structure
  • 12.3 Market Player Positioning
  • 12.4 Top Winning Strategies
  • 12.5 Competitive Dashboard
  • 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

  • 13.1 Company A
    • 13.1.1 Business Overview
    • 13.1.2 Services Offered
    • 13.1.3 Business Strategies
    • 13.1.4 SWOT Analysis
    • 13.1.5 Major News and Events
  • 13.2 Company B
    • 13.2.1 Business Overview
    • 13.2.2 Services Offered
    • 13.2.3 Business Strategies
    • 13.2.4 SWOT Analysis
    • 13.2.5 Major News and Events
  • 13.3 Company C
    • 13.3.1 Business Overview
    • 13.3.2 Services Offered
    • 13.3.3 Business Strategies
    • 13.3.4 SWOT Analysis
    • 13.3.5 Major News and Events
  • 13.4 Company D
    • 13.4.1 Business Overview
    • 13.4.2 Services Offered
    • 13.4.3 Business Strategies
    • 13.4.4 SWOT Analysis
    • 13.4.5 Major News and Events
  • 13.5 Company E
    • 13.5.1 Business Overview
    • 13.5.2 Services Offered
    • 13.5.3 Business Strategies
    • 13.5.4 SWOT Analysis
    • 13.5.5 Major News and Events

14 Japan In Vitro Diagnostics Market - Industry Analysis

  • 14.1 Drivers, Restraints, and Opportunities
    • 14.1.1 Overview
    • 14.1.2 Drivers
    • 14.1.3 Restraints
    • 14.1.4 Opportunities
  • 14.2 Porters Five Forces Analysis
    • 14.2.1 Overview
    • 14.2.2 Bargaining Power of Buyers
    • 14.2.3 Bargaining Power of Suppliers
    • 14.2.4 Degree of Competition
    • 14.2.5 Threat of New Entrants
    • 14.2.6 Threat of Substitutes
  • 14.3 Value Chain Analysis

15 Appendix